Search Results 611-620 of 16022 for pharmacogenetics
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
D., is a laboratory geneticist, with specialty interest in hereditary cancer predisposition syndromes and rare diseases. His focus includes: Comprehensive ...
About this study. The purpose of this registry is to develop a database of patient experience that can be used for internal research, education, ...
The purpose of this study is to examine if there is a difference in muscle activity in two different techniques of performing a lunge exercise. Participation ...
Patients with Acute Myeloid Leukemia (AML) in complete remission will receive eltrombopag while undergoing consolidation chemotherapy with high-dose cytarabine.
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...
In this procedure, specialists aim to fix or replace a faulty gene to try to cure a disease or make the body better able to fight a disease.
Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...
Type: Fellowship; Duration: 2 years; School: Graduate Medical Education; Specialty: Laboratory Medicine & Pathology ...
The purpose of this study is to establish a biorepository of biosamples from patients with spondyloarthritis (SpA). This biorepository will enable future ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.